Patel Gaurav, Kishore Reddy Bojja V, Patil Prakash
Department Of Surgical Oncology, Bombay Hospital and Medical Research Centre, Marine lines, Mumbai, 400020 India.
Indian J Surg Oncol. 2021 Jun;12(2):421-427. doi: 10.1007/s13193-021-01329-1. Epub 2021 Apr 27.
Metastatic breast cancer is not a curable disease, but women with metastatic disease are living longer. Although the relative survival has improved in recent years still patients who present with metastatic disease have a less than 30% 5-year survival. Historically, removal of the primary breast tumor has been offered to these patients only for palliation. However, there have been recent reports that removal of the primary tumor may improve survival. These are mostly retrospective studies limited by selection bias. Prospective and randomized trials have not shown a clear survival advantage. Although the definitive role of removal of the primary tumor in metastatic breast cancer is not settled, it is critical to understand the complexities of this debate in order to make further gains in breast cancer survivorship.
转移性乳腺癌是一种无法治愈的疾病,但患有转移性疾病的女性存活时间正在延长。尽管近年来相对生存率有所提高,但出现转移性疾病的患者5年生存率仍低于30%。从历史上看,这些患者仅在姑息治疗时才会切除原发性乳腺肿瘤。然而,最近有报道称,切除原发性肿瘤可能会提高生存率。这些大多是受选择偏倚限制的回顾性研究。前瞻性和随机试验并未显示出明显的生存优势。虽然切除原发性肿瘤在转移性乳腺癌中的明确作用尚未确定,但了解这场辩论的复杂性对于在乳腺癌生存方面取得进一步进展至关重要。